Obsidian Therapeutics, Inc. (OBX) SEC Filings & Financial Intelligence
Obsidian Therapeutics, Inc. (OBX) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: OBX
CIK: 2130606
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
KPMG LLP
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerJennifer Plotnick
Audit LocationBoston, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G | 2026-10-05 | — | SCHEDULE 13G Filing | 0001104659-26-113688 | View SEC Doc Filr Page |
| EFFECT | 2026-09-09 | — | EFFECT Filing | 9999999995-26-002925 | View SEC Doc Filr Page |
| S-1 | 2026-08-28 | — | S-1 | 0001193125-26-374729 | View SEC Doc Filr Page |
| 8-K/A | 2026-08-14 | 2026-07-31 | 8-K/A | 0001193125-26-352388 | View SEC Doc Filr Page |
| 10-Q | 2026-08-14 | 2026-06-30 | 10-Q | 0001193125-26-352381 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-11 | — | SCHEDULE 13G Filing | 0001172661-26-003281 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-10 | — | SCHEDULE 13G Filing | 0001628098-26-000007 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-10 | — | SCHEDULE 13G Filing | 0001346824-26-000218 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-10 | — | SCHEDULE 13G Filing | 0001388325-26-000037 | View SEC Doc Filr Page |
| 4 | 2026-08-05 | 2026-08-03 | 4 | 0001193125-26-335113 | View SEC Doc Filr Page |
| 4 | 2026-08-05 | 2026-08-03 | 4 | 0001193125-26-335083 | View SEC Doc Filr Page |
| 4 | 2026-08-05 | 2026-08-03 | 4 | 0001193125-26-335082 | View SEC Doc Filr Page |
| 4 | 2026-08-05 | 2026-08-03 | 4 | 0001193125-26-335078 | View SEC Doc Filr Page |
| 4 | 2026-08-05 | 2026-08-03 | 4 | 0001193125-26-335055 | View SEC Doc Filr Page |
| 4 | 2026-08-05 | 2026-08-03 | 4 | 0001193125-26-335045 | View SEC Doc Filr Page |
| 3 | 2026-08-03 | 2026-08-03 | 3 | 0001193125-26-331005 | View SEC Doc Filr Page |
| 3 | 2026-08-03 | 2026-08-03 | 3 | 0001193125-26-331002 | View SEC Doc Filr Page |
| 3 | 2026-08-03 | 2026-08-03 | 3 | 0001193125-26-330998 | View SEC Doc Filr Page |
| 3 | 2026-08-03 | 2026-08-03 | 3 | 0001193125-26-330988 | View SEC Doc Filr Page |
| 3 | 2026-08-03 | 2026-08-03 | 3 | 0001193125-26-330982 | View SEC Doc Filr Page |
| 3 | 2026-08-03 | 2026-08-03 | 3 | 0001193125-26-330979 | View SEC Doc Filr Page |
| 3 | 2026-08-03 | 2026-08-03 | 3 | 0001193125-26-330977 | View SEC Doc Filr Page |
| 3 | 2026-08-03 | 2026-08-03 | 3 | 0001193125-26-330973 | View SEC Doc Filr Page |
| S-8 | 2026-08-03 | — | S-8 | 0001193125-26-330881 | View SEC Doc Filr Page |
| 8-K | 2026-08-03 | 2026-07-31 | 8-K | 0001193125-26-330810 | View SEC Doc Filr Page |